Skip Nav Destination
Yttrium-90 Ibritumomab Tiuxetan Followed by Rituximab Maintenance as Treatment for Patients with Diffuse Large B-Cell Lymphoma Are Not Candidates for Autologous Stem Cell Transplant
Acta Haematol (2015) 133 (4): 347–353.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Matthew Mei
- Joycelynne Palmer
- Nicole Ni-Chun Tsai
- Jennifer Simpson
- James O'Hearn
- Anthony Stein
- Stephen Forman
- Ricardo Spielberger
- Ji-Lian Cai
- Myo Htut
- Ryotaro Nakamura
- Monzr M. Al Malki
- Alex Herrera
- Jeffrey Wong
- Auayporn Nademanee
Clinical Lymphoma Myeloma and Leukemia (2023) 23 (9): e268.
- Jinchul Kim
- Jinhyun Cho
- Sang Eun Yoon
- Won Seog Kim
- Seok Jin Kim
Cancer Research and Treatment (2023) 55 (3): 1031.
- Julie Brogaard Larsen
- Johanne Andersen Hojbjerg
- Anne-Mette Hvas
Seminars in Thrombosis and Hemostasis (2020) 46 (03): 328.
- Vincent Camus
- Hervé Tilly
Expert Review of Hematology (2017) 10 (12): 1047.
- Yuze Cao
- Xiaoyan Lu
- Jianjian Wang
- Huixue Zhang
- Zhaojun Liu
- Si Xu
- Tianfeng Wang
- Shangwei Ning
- Bo Xiao
- Lihua Wang
International Journal of Molecular Medicine (2017) 39 (2): 268.
- Craig Erker
- Paul Harker-Murray
- Michael J Burke
Future Oncology (2016) 12 (2): 257.
- Piotr Smolewski
- Tadeusz Robak
Expert Opinion on Drug Discovery (2015) 10 (7): 791.